Entity usage

Jump to navigation Jump to search

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 24 results in range #1 to #24.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Section 5: Potential explanation for the difference between children and adults in COVID-19 (from DOI: 10.1016/j.clim.2020.108427): Title, Label: en
  2. Section 2: Epidemiological data of COVID-19 (from DOI: 10.1016/j.clim.2020.108427): Title, Label: en
  3. Section 1: Introduction (from DOI: 10.1016/j.clim.2020.108427): Title, Label: en
  4. Section 1: Introduction (from DOI: 10.1016/j.adro.2020.04.015): Title, Label: en
  5. Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x): Title, Label: en
  6. Section 3: COVID-19: Neuro-invasive potential of SARS-nCoV-2 as cause of delirium (from DOI: 10.1186/s13054-020-02882-x): Title, Label: en
  7. Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3): Title, Label: en
  8. Section 6: Host-Specific Variations in COVID-19 Immune Response (from DOI: 10.1007/s11886-020-01292-3): Title, Label: en
  9. Section 4: Viral Toxicity and Myocardial Injury in COVID-2 (from DOI: 10.1007/s11886-020-01292-3): Title, Label: en
  10. Section 1: Introduction (from DOI: 10.1007/s11886-020-01292-3): Title, Label: en
  11. Section 2.3: Congenital and perinatal infections with SARS-CoV-2 (from DOI: 10.1016/j.jcv.2020.104372): Title, Label: en
  12. Section 2.2: Congenital and perinatal infections with coronaviruses other than SARS-CoV-2 (from DOI: 10.1016/j.jcv.2020.104372): Title, Label: en
  13. Section 1: Introduction (from DOI: 10.1016/j.jcv.2020.104372): Title, Label: en
  14. Section 3.1.2: Arrhythmia (from DOI: 10.1007/s11886-020-01293-2): Title, Label: en
  15. Section 3.1: Cardiac Complications of COVID-19 (from DOI: 10.1007/s11886-020-01293-2): Title, Label: en
  16. Section 3: Cardiovascular Comorbidities and COVID-19 Outcomes (from DOI: 10.1007/s11886-020-01293-2): Title, Label: en
  17. Section 1: Introduction (from DOI: 10.1007/s11886-020-01293-2): Title, Label: en
  18. Section 6: Conclusions (from DOI:10.14218/ERHM.2020.00023): Title, Label: en
  19. Section 4: Discussion (from DOI:10.14218/ERHM.2020.00023): Title, Label: en
  20. Section 3: Results (from DOI:10.14218/ERHM.2020.00023): Title, Label: en
  21. Section 2: Methods (from DOI:10.14218/ERHM.2020.00023): Title, Label: en
  22. Section 1: Introduction (from DOI:10.14218/ERHM.2020.00023): Title, Label: en
  23. Introduction section from DOI: 10.1186/s13613-020-00653-z: Title, Label: en
  24. Discussion section from DOI: 10.1186/s13613-020-00653-z: Title, Label: en

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)